CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MultiTheranostic project aims to develop innovative nanoparticles for treating metastatic melanoma by combining gene therapy and chemotherapy. It seeks to enhance immune response and improve drug delivery using magnetic hyperthermia and MRI tracking.
Cancer is a leading cause of death and a major impediment to increasing life expectancy around the globe.
Amongst all skin cancers, melanoma is a hard-to-treat disease, owing to its high potential for metastasis, and it remains as one of the most aggressive cancers.
Single therapy is not efficient to tackle metastatic melanoma and a combination of therapies is thus emerging as a necessity to efficiently eradicate all cancer cells.
Recently, immunotherapy, in particular immune checkpoint inhibito…
LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA LIN
INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
